Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction
- 1 August 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 39 (8) , 1550-1564
Abstract
Despite decades of therapeutic advances, myocardial infarction remains a leading cause of death worldwide. Recent studies have identified HDLs (high-density lipoproteins) as a potential candidate for mitigating coronary ischemia/reperfusion injury via a broad spectrum of signaling pathways. HDL ligands, such as S1P (sphingosine-1-phosphate), Apo (apolipoprotein) A-I, clusterin, and miRNA, may influence the opening of the mitochondrial channel, insulin sensitivity, and production of vascular autacoids, such as NO, prostacyclin, and endothelin-1. In parallel, antioxidant activity and sequestration of oxidized molecules provided by HDL can attenuate the oxidative stress that triggers ischemia/reperfusion. Nevertheless, during myocardial infarction, oxidation and the capture of oxidized and proinflammatory molecules generate large phenotypic and functional changes in HDL, potentially limiting its beneficial properties. In this review, new findings from cellular and animal models, as well as from clinical studies, will be discussed to describe the cardioprotective benefits of HDL on myocardial infarction. Furthermore, mechanisms by which HDL modulates cardiac function and potential strategies to mitigate postmyocardial infarction risk damage by HDL will be detailed throughout the review.Keywords
This publication has 140 references indexed in Scilit:
- Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in miceGene Therapy, 2013
- Cytoprotection by the modulation of mitochondrial electron transport chain: The emerging role of mitochondrial STAT3Mitochondrion, 2012
- Mitochondrial-targeted Signal Transducer and Activator of Transcription 3 (STAT3) Protects against Ischemia-induced Changes in the Electron Transport Chain and the Generation of Reactive Oxygen SpeciesJournal of Biological Chemistry, 2011
- Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusionBasic Research in Cardiology, 2010
- Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2Nature, 2010
- Modifying Apolipoprotein A-I by Malondialdehyde, but Not by an Array of Other Reactive Carbonyls, Blocks Cholesterol Efflux by the ABCA1 PathwayJournal of Biological Chemistry, 2010
- Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transitionProceedings of the National Academy of Sciences, 2009
- Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescueJournal of Bioenergetics and Biomembranes, 2009
- Sphingosine-1-phosphate receptor signalling in the heartCardiovascular Research, 2008
- Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemiaBiochemical and Biophysical Research Communications, 2008